Background Cancer is a set of diseases characterized by unchecked cell proliferation and
invasion of surrounding tissues. The many genes that have been genetically associated with …

Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with the most
unfavorable clinical outcomes, in part due to tumor heterogeneity, treatment resistance, and …

Simple Summary This study aimed to identify genes associated with neoadjuvant
chemotherapy (NAC) response and disease-free survival (DFS) of triple-negative breast …

Molecular subtyping of triple-negative breast cancer (TNBC) is essential for understanding
the mechanisms and discovering actionable targets of this highly heterogeneous type of …

Background Triple-negative breast cancer (TNBC) patients who recur at different times are
associated with distinct biological characteristics and prognoses. Research on rapid-relapse …

Simple Summary Chemoimmunotherapy combinations have transformed the treatment
landscape for patients with triple-negative breast cancer (TNBC). However, the discovery of …

Background Up to 30% of breast cancer (BC) patients treated with neoadjuvant
chemotherapy (NCT) will relapse. Our objective was to analyze the predictive capacity of …

Background: Despite advances in the treatment of early triple-negative breast cancer
(TNBC), patients with residual invasive disease after neoadjuvant therapy have a high risk of …

Introduction This study examines the association between hospital volume and all-cause
mortality in Black women with triple negative breast cancer (TNBC) who received surgery …

Aim: This study aimed to predict axillary metastasis using radiology features in dynamic
contrast-enhanced MRI. Methods: This study included 243 breast lesions confirmed as …